We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...

Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Following Palantir’s breakthrough as a key player in AI software analyst Dan Ives has identified the next stock to follow ...

The Stellantis 2024 roller coaster hit a new low with CEO Carlos Tavares’s abrupt resignation. Here are three areas a new CEO ...

Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...

The $7 billion RIA welcomes a seasoned professional to help scale the business and draw talent across its private-client and ...

(Bloomberg) — Wedbush Securities, the Los Angeles-based brokerage consistently ranked among the top firms by Nasdaq trading volume, was accused by the U.S. Securities and Exchange Commission of ...

Wedbush assumed coverage of Passage Bio (PASG) with an Outperform rating and price target of $4, up from $3. Market sentiment may be different from the days when an extensive gene therapy pipeline ...